ArticleJournal of thoracic disease2022

Tracking and tackling the tumor dynamics clonal evolution: osimertinib rechallenge after interval therapy might be an effective treatment approach in

Giulio Metro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.